Fasiglifam, TAK-875
Cikakken Bayani
Tags samfurin
| Girman Kunshin | samuwa | Farashin (USD) |
Sunan Sinadari:
(S) -2- (6- ((2',6'-dimethyl-4'- (3- (methylsulfonyl) propoxy)-[1,1'-biphenyl] -3-yl) methoxy) -2,3 Dihydrobenzofuran-3-yl) acetic acid
Lambar SMILES:
O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3 = CC=C12
Lambar InChi:
InChi=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21( 14-22) 17-35-24-8-9-2 6-23 (15-28 (30)31)18-36-27 (26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2, 1-3H3, (H,30,31)/t23-/m1/s1
InChi Key:
BZCALJIHZVNMGJ-HSZRJFAPSA-N
Mabuɗin kalma:
1000413-72-8;CAS:1000413-72-8;CAS:1000413-72-8;TAK875;TAK-875;TAK 875
Solubility:Mai narkewa a cikin DMSO, ba cikin ruwa ba
Ajiya:0 - 4 C na gajeren lokaci (kwanaki zuwa makonni), ko -20 C na dogon lokaci (watanni).
Bayani:
Fasiglifam (TAK-875) tasiri ne, na baka, da kuma zaɓaɓɓen agonist na GPR40.
Bayani: GPR40 agonist
